Chr Hansen A/S : Q2 Roadshow presentation 2021/22

Safe harbor statement

This presentation contains forward-looking statements that reflect management's current views and expectations with respect to Chr. Hansen's future and potential financial performance.

Those forward-looking statements are based upon data and information currently available to the company, and on a variety of assumptions, many of which may be beyond our control and subject to risks and uncertainties that may cause the actual results of the Company or the industry to differ materially from such forward-looking statements.

The information, opinions and forward-looking statements contained in this document speak only as at the date of it and the company is under no obligation to publish any updates thereof except for what is required by applicable law or stock exchange rules and regulations.

Statement on Ukraine and Russia

We are appalled by the escalating violence in Ukraine and condemn the Russian invasion in the strongest possible terms. Our hearts and thoughts go out to the people of Ukraine.

As a global supplier to the food and health industries, we have responsibilities towards fulfilling the basic needs of civilians for food and health products, also in Russia. For now, we will therefore continue to supply only ingredients for basic food and human health products, in full respect of global sanctions. We are discontinuing supply of products that fall outside these categories.

We have decided that all profit from our continued operations in Chr. Hansen LLC, Russia during the conflict will be donated to humanitarian aid in support of Ukraine.

We continuously evaluate further potential changes in our activities as the situation develops. At the same time, we are specifically monitoring sanctions and people safety in the supply chain. Our top priority continues to be on the safety of our affected employees and their families in Ukraine.

Ukraine accounts for <1% and Russia/Belarus for 3-4% of Chr. Hansen Group revenue

No production or sourcing of critical raw materials

Strong performance in a challenging environment

Financial highlights Q2/YTD 2021/22

ORGANIC GROWTH	EBIT MARGIN	FREE CASH FLOW
before special items	before acquisitions and special items
14%	EUR 31m
YTD 2021/22: 12%	YTD 2021/22: EUR 86m

(+0.7% vs. LY)

27.7%

YTD 2021/22: 26.2%

(+0.1% vs. LY)

Growth driven by core businesses; lighthouses on track

Strategic and operational highlights Q2/YTD 2021/22

2025 STRATEGY

1 Core includes FC&E ex. Bioprotection and Fermented Plant Bases, Human Health and Animal Health. Lighthouses includes Bioprotection, Fermented Plant Bases, HMO and Plant Health.

ORGANIC GROWTH

Q2/YTD 2021/22

22%

Core 1

Lighthouses1

Q2 21/22

GroupYTD 21/22